临床实践中双重核苷类逆转录酶抑制剂治疗期间人类免疫缺陷病毒1型RNA的长期抑制
Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice.
作者信息
Hoesley C J, Saag M S, Chatham A, Kilby J M
机构信息
Division of Infectious Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294-2050, USA.
出版信息
Clin Infect Dis. 2000 Oct;31(4):1095-7. doi: 10.1086/318143.
DOI:10.1086/318143
PMID:11049795
Abstract
Because there is limited information about suppression of virus loads (determined by current "ultrasensitive" assays) in patients receiving nucleoside reverse-transcriptase inhibitors (NRTIs) alone, we reviewed our experience in clinical practice with patients who had virus loads of <25 copies/mL after >1 year of treatment with dual NRTIs.
摘要
由于关于仅接受核苷类逆转录酶抑制剂（NRTIs）治疗的患者中病毒载量抑制情况（通过当前的“超敏”检测方法测定）的信息有限，我们回顾了在临床实践中对接受双联NRTIs治疗1年以上后病毒载量<25拷贝/毫升的患者的治疗经验。
Zotero 插件